Oregonians Deserve Access to the Best Tools in Treating Serious Disease
SALEM, Oregon –– Improved coverage of comprehensive biomarker testing is crucial for Oregonians to have the best chance of treating and defeating cancer and other diseases.
SALEM, Oregon –– Improved coverage of comprehensive biomarker testing is crucial for Oregonians to have the best chance of treating and defeating cancer and other diseases.
DOVER, DE – The Delaware State Senate has unanimously passed legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it.
Tras meses de debate, los legisladores estatales finalizaron el presupuesto del estado de Nueva York, optando por preservar el acceso a las pruebas de biomarcadores para las personas inscritas en Medicaid.
La Legislatura de Illinois aprobó un proyecto de ley para incrementar el acceso a las pruebas de biomarcadores, una herramienta transformadora en la lucha contra el cáncer y otras enfermedades, y un paso esencial para acceder a tratamientos de precisión.
Late Friday, the Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS) released a final rule on the Patient Protection and Affordable Care Act HHS Notice of Benefit and Payment Parameters (NBPP) for plan year 2027.
Cancer Advocates Gathered at the Statehouse Today to Say Ohio Can and Must Do Better to Reduce the Burden of Cancer
Visual Elements Available for Download:
NASHVILLE, Tenn. – Gov.
RALEIGH, N.C. – Cancer advocates, patients, survivors and caregivers from around the state will gather at the General Assembly on Tuesday, May 12, to ask lawmakers to make cancer policy a priority for Cancer Action Day hosted by the American Cancer Society Cancer Action Network (
Illinois Must Do Better to Reduce the Burden of Cancer